New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
27 02 2019
Historique:
received: 29 10 2018
accepted: 07 02 2019
entrez: 1 3 2019
pubmed: 1 3 2019
medline: 22 9 2020
Statut: epublish

Résumé

The use of O-(2-[

Identifiants

pubmed: 30814660
doi: 10.1038/s41598-019-40013-x
pii: 10.1038/s41598-019-40013-x
pmc: PMC6393465
doi:

Substances chimiques

Large Neutral Amino Acid-Transporter 1 0
Radiopharmaceuticals 0
SLC7A5 protein, human 0
(18F)fluoroethyltyrosine 1326R5J1IA
Tyrosine 42HK56048U

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2878

Références

J Med Chem. 2018 Aug 23;61(16):7358-7373
pubmed: 30048132
J Nucl Med. 2013 Dec;54(12):2046-54
pubmed: 24159047
J Nucl Med. 2012 Aug;53(8):1253-61
pubmed: 22743251
Biomed Res Int. 2013;2013:460619
pubmed: 23936803
Neuro Oncol. 2016 Mar;18(3):426-34
pubmed: 26243791
Eur J Nucl Med Mol Imaging. 2002 May;29(5):681-90
pubmed: 11976809
Org Lett. 2012 Feb 3;14(3):696-9
pubmed: 22260734
Front Chem. 2018 Jan 15;5:124
pubmed: 29379780
Nat Rev Neurol. 2017 May;13(5):279-289
pubmed: 28387340
Semin Cancer Biol. 2005 Aug;15(4):254-66
pubmed: 15916903
Eur J Nucl Med Mol Imaging. 2006 Aug;33(8):919-27
pubmed: 16572305
Med Res Rev. 2012 Jul;32(4):868-905
pubmed: 21793016
J Nucl Med. 2007 Sep;48(9):1468-81
pubmed: 17704239
J Nucl Med. 2004 Sep;45(9):1591-6
pubmed: 15347729
J Med Chem. 2016 Jun 9;59(11):5324-40
pubmed: 27191773
J Nucl Med. 2006 May;47(5):776-82
pubmed: 16644747
Int J Mol Sci. 2018 Jan 30;19(2):
pubmed: 29385713
Neuroimage Clin. 2016 Dec 18;13:386-394
pubmed: 28116231
Ann Nucl Med. 2013 May;27(4):314-24
pubmed: 23337966
Int J Mol Sci. 2016 Oct 14;17(10):
pubmed: 27754421
Neurochem Int. 2003 Sep-Oct;43(4-5):289-98
pubmed: 12742071
Mol Aspects Med. 2013 Apr-Jun;34(2-3):139-58
pubmed: 23506863
Eur J Nucl Med. 1998 Jun;25(6):629-33
pubmed: 9618578
Nucl Med Biol. 2011 Jul;38(5):645-51
pubmed: 21718939
Eur J Nucl Med Mol Imaging. 2017 May;44(5):812-821
pubmed: 27900521
Neuro Oncol. 2013 Mar;15(3):341-51
pubmed: 23335162
Nucl Med Biol. 2018 May;60:19-28
pubmed: 29525446
Nucl Med Biol. 2015 Jan;42(1):38-45
pubmed: 25218024
Nucl Med Biol. 2003 Jul;30(5):501-8
pubmed: 12831987
Mol Pharm. 2011 Oct 3;8(5):1857-66
pubmed: 21770378
Q J Nucl Med Mol Imaging. 2012 Apr;56(2):173-90
pubmed: 22617239
Nucl Med Biol. 2011 Jan;38(1):53-62
pubmed: 21220129
Amino Acids. 2015 Feb;47(2):335-44
pubmed: 25385314
Q J Nucl Med Mol Imaging. 2015 Mar;59(1):70-82
pubmed: 25517079
Neuro Oncol. 2012 Aug;14(8):979-93
pubmed: 22679124
J Neurooncol. 2009 Sep;94(3):299-312
pubmed: 19381449
Am J Cancer Res. 2015 Mar 15;5(4):1281-94
pubmed: 26101697
BMC Clin Pathol. 2012 Feb 28;12:4
pubmed: 22373026
Angew Chem Int Ed Engl. 2016 Aug 8;55(33):9676-9
pubmed: 27380912
Nucl Med Biol. 2006 Aug;33(6):735-41
pubmed: 16934692
J Med Chem. 2016 Apr 14;59(7):3515-31
pubmed: 26967318
Nucl Med Biol. 2011 Apr;38(3):301-12
pubmed: 21492778
EJNMMI Res. 2017 Dec;7(1):50
pubmed: 28567708
Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):519-24
pubmed: 12589478
Cancer Metastasis Rev. 2008 Dec;27(4):555-73
pubmed: 18648909
Am J Nucl Med Mol Imaging. 2014 Jun 07;4(4):365-84
pubmed: 24982822

Auteurs

Jeroen Verhoeven (J)

Laboratory of Radiopharmacy, Ghent University, Ghent, Belgium. Jeroen.Verhoeven@ugent.be.

Fabian Hulpia (F)

Laboratory for Medicinal Chemistry, Ghent University, Ghent, Belgium.

Ken Kersemans (K)

Ghent University Hospital, Department of Nuclear Medicine, Ghent, Belgium.

Julie Bolcaen (J)

Ghent University Hospital, Department of Nuclear Medicine, Ghent, Belgium.

Stef De Lombaerde (S)

Laboratory of Radiopharmacy, Ghent University, Ghent, Belgium.

Jan Goeman (J)

Laboratory for Organic and Bio-organic synthesis, Ghent University, Ghent, Belgium.

Benedicte Descamps (B)

IBiTech-MEDISIP Ghent University, Department of Electronics and Information Systems, Ghent, Belgium.

Giorgio Hallaert (G)

Ghent University Hospital, Department of Neurosurgery, Ghent, Belgium.

Caroline Van den Broecke (C)

Ghent University Hospital, Department of Pathology, Ghent, Belgium.

Karel Deblaere (K)

Ghent University Hospital, Department of Radiology and Medical Imaging, Ghent, Belgium.

Christian Vanhove (C)

IBiTech-MEDISIP Ghent University, Department of Electronics and Information Systems, Ghent, Belgium.

Johan Van der Eycken (J)

Laboratory for Organic and Bio-organic synthesis, Ghent University, Ghent, Belgium.

Serge Van Calenbergh (S)

Laboratory for Medicinal Chemistry, Ghent University, Ghent, Belgium.

Ingeborg Goethals (I)

Ghent University Hospital, Department of Nuclear Medicine, Ghent, Belgium.

Filip De Vos (F)

Laboratory of Radiopharmacy, Ghent University, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH